Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Finally, reach out to your healthcare team for guidance on replacing the expired medication and adjusting your treatment plan
The FDA cleared orforglipron for chronic weight management in adults with obesity, or overweight with at least one weight-related comorbidity, based on the ATTAIN clinical program which showed placebo-adjusted weight loss of 7.5% to 11.2% in non-diabetics (ATTAIN-1) and 5.1% to 9.6% in diabetics at different doses, along with the expected glycaemic benefits (ATTAIN-2)
Diets high in refined carbohydrates and low in protein or fiber can cause rapid blood glucose fluctuations, triggering hunger signals despite adequate caloric intake
Curcumin has demonstrated the ability to enhance GLP-1 signaling pathways and may support insulin sensitivity and metabolic health
The Ethics Case for Longevity Science Zhuang Zhuang Han, Joo Pedro de Magalhes
